Question · asked by 1 review
Inhaled NO vs placebo or conventional therapy: Difference in MPAP change score (SE) ‐ Placebo4
- Population
- all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
- Intervention
- Inhaled NO
- Comparison
- placebo or conventional therapy
- Outcome
- Difference in MPAP change score (SE) ‐ Placebo4
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Inhaled nitric oxide vs placebo or conventional therapy Difference in MPAP change score (SE) ‐ Placebo4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with… (2014) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 2 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease 2014 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.